Skip to content

EyePoint, Inc. EYPT Product Rights Agreement — Upfront Cash Payment

Other product segments

Royalty Purchase Agreement
$16.5M0.0%

Similar metrics at other companies

Opko Health logo
OPKTransfer Of Intellectual Property And Other — Upfront Payment
$1.75M
Septerna, Inc. logo
SEPNMaterial Right — Non Refundable One Time Upfront Payment Received
$41.2M+300%
Praxis Precision Medicines, Inc. logo
PRAXLicense — Upfront payment
$0
Harmony Biosciences Holdings, Inc. logo
HRMYPayment Of Upfront Fee Investing Activities
$32M+753%
Harmony Biosciences Holdings, Inc. logo
HRMYPitolisants — License Agreement Upfront Fee Paid
$15M
Septerna, Inc. logo
SEPNResearch Development Programs And Manufacturing Services — Non Refundable One Time Upfront Payment Received
$153.8M+300%

Other financials

Income statement

See full
Revenue$696.0K-97.2%
Gross profit$9.8M-30.1%
Operating income-$87.2M-78.6%
Net income-$84.8M-87.7%
EPS (diluted)-$0.99-52.3%

Balance sheet

See full
Cash & equivalents$77.7M-8.7%
Total debt$22.3M-7.3%
Total equity$230.5M-22.8%
Total assets$288.2M-20.5%

Cash flow

See full
Operating cash flow-$80.5M-51.6%
CapEx$997.0K+261%
Free cash flow-$81.5M-52.7%

Valuation

See full
Market cap$1.21B+189%
Enterprise value$1.15B+228%
P/S158.5×+151×

Profitability

See full
Operating margin-3,700.9%-4,042pp
Net margin-3,566.6%-3,874pp
FCF margin-3,565.9%-3,884pp

Returns & leverage

See full
Return on equity-102.7%+1,157pp
Debt / equity0.1×0.0×
Current ratio6.7×-1.2×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept eypt:UpfrontCashPayment.

The official record: EyePoint, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's product rights agreement — upfront cash payment.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EyePoint, Inc. 's product rights agreement — upfront cash payment?
EyePoint, Inc. (EYPT) reported product rights agreement — upfront cash payment of $75M in Q1 2026.
How has EyePoint, Inc. 's product rights agreement — upfront cash payment changed year-over-year?
EyePoint, Inc. 's product rights agreement — upfront cash payment decreased by 0.0% year-over-year, from $75M to $75M.
What does product rights agreement — upfront cash payment mean?
Represents the initial, non-refundable cash consideration received or paid at the inception of a licensing or product rights agreement. This metric reflects the immediate capital exchange for granting or acquiring access to intellectual property or commercialization rights. It serves as a key indicator of the initial valuation and commitment level between contracting parties.